Assertio Therapeutics, Inc

CIK 1005201 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Assertio Therapeutics, Inc.

Recent SEC filings

FiledFormAccession number
Jun 16, 202625-NSE0001354457-26-000582
Feb 12, 2021SC 13G/A0001193125-21-041185
Jun 18, 202015-12B0001104659-20-074525
May 22, 20208-K0001104659-20-065440
May 19, 202025-NSE0001354457-20-000198
May 18, 2020DEFA14A0001104659-20-063224
May 11, 202040001005201-20-000037
May 11, 20204250001005201-20-000033
May 11, 202010-Q0001005201-20-000035
May 11, 20208-K0001005201-20-000034
Apr 24, 20208-K0001104659-20-051058
Apr 21, 20208-K0001104659-20-048835
Apr 21, 20204250001104659-20-048836
Apr 20, 2020DEF 14A0001047469-20-002442
Apr 8, 20208-K0001104659-20-044677
Apr 8, 2020SC TO-I/A0001104659-20-044680
Apr 3, 202040001005201-20-000025
Apr 3, 20204/A0001005201-20-000027
Mar 31, 202040001005201-20-000023
Mar 26, 2020SC 13D0001104659-20-038823
Mar 25, 2020SC TO-I/A0001104659-20-037954
Mar 17, 20204250001104659-20-034381
Mar 17, 20208-K0001104659-20-034380
Mar 11, 20208-K0001104659-20-031583
Mar 11, 2020SC TO-I0001047469-20-001372